Article
Covid-19: India Says Homegrown mRNA Shot Safe in Early Trial
Rating:
0.0
Views:
56
Likes:
1
Library:
1
The Covid-19 vaccine of Indian pharmaceutical firm Gennova Biopharmaceuticals, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value